Public LEI record · Global LEI Index

Hong Kong

CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF

C/O CHINA ASSET MANAGEMENT (HONG KONG) LIMITED, 37/F BANK OF CHINA TOWER, 1 GARDEN ROAD, HONG KONG, HK

Legal Entity Identifier 213800Y5ZKGD6STOL630
Entity status
Active
LEI status
Issued
Policy conformity
Conforming
Reference data
Entity-supplied
Next renewal
2 Jul 2027
LEI Issuer
London Stock Exchange

Record snapshot

The Legal Entity Identifier for CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF is 213800Y5ZKGD6STOL630. It is valid, policy conforming and renewed until 2 Jul 2027.

CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF is a SUB-FUND formed in Hong Kong. The LEI was registered on 2 Jul 2026. Its reference data comes from documents the entity supplied rather than from a check against an authoritative public source. It reports no parent, on the grounds that no parent prepares consolidated accounts that include it. CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF is a sub-fund of CHINAAMC CHOICE FUND, managed by 華夏基金(香港)有限公司. London Stock Exchange maintains the record.

256 Days left in this cycle
Transfer to RapidLEI A transfer changes which LEI Issuer manages the record. The LEI code and its reference data do not change.

Record lifecycle

In its first registration period.

First LEI registered on 2 Jul 2026. The next renewal falls due on 2 Jul 2027, which is 9 months from today.

2 Jul 2026 LEI issued 2 Jul 2027 Next renewal due

Registered entity Level 1 data

Legal name
CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF
Legal form
SUB-FUND 8888
Former legal name
CHINAAMC FRANKLIN FTSE GLOBAL INNOVATIVE DRUGS ETF
Category
Fund
Jurisdiction
Hong Kong HK
Registration
No authoritative public source on GLEIF's list covers this entity type.
Entity created
30 Jun 2026
Legal address
C/O CHINA ASSET MANAGEMENT (HONG KONG) LIMITED, 37/F BANK OF CHINA TOWER, 1 GARDEN ROAD, HONG KONG, HK
Connected identifiers
S&P Capital IQ2008821078 Other identifiers recorded against this LEI.
Securities
Not recorded No ISIN is mapped to this LEI in the ANNA and GLEIF ISIN-to-LEI file. That records the absence of a mapping, not the absence of securities.

What this record’s status means

Reference data
Entity-supplied GLEIF records this as entity supplied. No authoritative public source on GLEIF's list covers this entity type, so there was nothing to check the data against. It was validated against documents the entity provided.

Changes to this record

Not retrieved yet. The change history for this record has not been retrieved yet.

Ownership Level 2 data

  1. Ultimate parent
    No consolidating parent Reported exception No parent consolidates this entity
  2. Direct parent
    No consolidating parent Reported exception No parent consolidates this entity
  3. This entity

    CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF

    HK · 213800Y5ZKGD6STOL630

    Active

  4. Below
    0 Direct subsidiaries
    0 Ultimate subsidiaries

    The chain ends here. No other entity reports CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF as its parent, so the count is a stated zero rather than data still to arrive.

Level 2 data records who consolidates this entity. A reported relationship, or a reported reason for the absence of one, both satisfy the standard. Only a record carrying neither is incomplete. This is usual for funds. Umbrella, manager and sub-fund relationships are recorded in the fund structure below.

Fund structure Reported to GLEIF

  1. Managed by
  2. Umbrella
  3. This entity

    CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF

    HK · 213800Y5ZKGD6STOL630

    Active

  4. Below
    0 Sub-funds

    No other fund reports CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF as its umbrella, so the count is a stated zero rather than data still to arrive.

GLEIF records fund relationships separately from the consolidation parents above. A sub-fund reporting no consolidating parent is the ordinary case, and says nothing about the structure shown here.

Where this data comes from

Source registry

None applies to this entity type

Validated against

Documents supplied by the entity, reviewed by the LEI Issuer

Maintained by

London Stock Exchange

Published in

The GLEIF Global LEI Index. This record last updated 29 Jul 2026

CHINAAMC FRANKLIN FTSE INNOVATIVE DRUGS ETF

Add this schema to your homepage. Replace the two example.com values with your own homepage address before publishing.

How to use this

Reference data from the GLEIF Global LEI Index, as published on 29 Jul 2026.